A carregar...
A highly specific SpCas9 variant is identified by in vivo screening in yeast
Despite the utility of CRISPR-Cas9 nucleases for genome editing, the potential for off-target activity limits their application, especially for therapeutic purposes1,2. We developed a yeast-based assay to identify optimized Streptococcus pyogenes Cas9 (SpCas9) variants that enables simultaneous eval...
Na minha lista:
| Publicado no: | Nat Biotechnol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6066108/ https://ncbi.nlm.nih.gov/pubmed/29431739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.4066 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|